These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36702538)

  • 1. Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.
    Ho S; Oswald E; Wong HK; Vural A; Yilmaz V; Tüzün E; Türkoğlu R; Straub T; Meinl I; Thaler F; Kümpfel T; Meinl E; Mader S
    Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36702538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis.
    Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of Isoforms of Human Soluble TACI.
    Fichtner ML; Rübsamen H; Smolle M; Schaller J; Feederle R; Bültmann A; Kümpfel T; Schneider P; Thaler FS; Meinl E
    J Immunol; 2023 Jul; 211(2):199-208. PubMed ID: 37272840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
    Hoffmann FS; Kuhn PH; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister HW; Alexander T; Hiepe F; Kümpfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
    J Immunol; 2015 Jan; 194(2):542-52. PubMed ID: 25505277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
    Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
    Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
    Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
    Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus.
    Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Hoi AY; Harris J; Mackay F; Morand EF
    Clin Transl Immunology; 2019; 8(4):e01047. PubMed ID: 31024730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myeloma.
    Meinl E; Krumbholz M
    Curr Opin Immunol; 2021 Aug; 71():117-123. PubMed ID: 34330018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of TNF-α superfamily members in immunopathogenesis of sepsis.
    Lendak DF; Mihajlović DM; Novakov-Mikić AS; Mitić IM; Boban JM; Brkić SV
    Cytokine; 2018 Nov; 111():125-130. PubMed ID: 30142533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
    He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
    J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APRIL and sTACI could be predictors of multiorgan dysfunction syndrome in sepsis.
    Lendak DF; Mihajlović DM; Novakov-Mikić AS; Boban JM; Ubavić M; Brkić SV
    Virulence; 2018 Dec; 9(1):946-953. PubMed ID: 29781374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.
    Miyazaki Y; Niino M; Takahashi E; Suzuki M; Mizuno M; Hisahara S; Fukazawa T; Amino I; Nakano F; Nakamura M; Akimoto S; Minami N; Fujiki N; Doi S; Shimohama S; Terayama Y; Kikuchi S
    Clin Immunol; 2018 Feb; 187():95-101. PubMed ID: 29079163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis.
    Smets I; Prezzemolo T; Imbrechts M; Mallants K; Mitera T; Humblet-Baron S; Dubois B; Matthys P; Liston A; Goris A
    Front Immunol; 2021; 12():676619. PubMed ID: 34122439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of free and ligand-bound atacicept in human serum.
    Eslami M; Willen D; Papasouliotis O; Schuepbach-Mallpell S; Willen L; Donzé O; Yalkinoglu Ö; Schneider P
    Front Immunol; 2022; 13():1035556. PubMed ID: 36532058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2.
    Mongini PK; Inman JK; Han H; Fattah RJ; Abramson SB; Attur M
    J Immunol; 2006 Jun; 176(11):6736-51. PubMed ID: 16709833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells in MS and NMO: pathogenesis and therapy.
    Krumbholz M; Meinl E
    Semin Immunopathol; 2014 May; 36(3):339-50. PubMed ID: 24832354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B Cell-Activating Factor Neutralization Aggravates Atherosclerosis.
    Tsiantoulas D; Sage AP; Göderle L; Ozsvar-Kozma M; Murphy D; Porsch F; Pasterkamp G; Menche J; Schneider P; Mallat Z; Binder CJ
    Circulation; 2018 Nov; 138(20):2263-2273. PubMed ID: 29858401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
    Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
    Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
    Moreaux J; Legouffe E; Jourdan E; Quittet P; Rème T; Lugagne C; Moine P; Rossi JF; Klein B; Tarte K
    Blood; 2004 Apr; 103(8):3148-57. PubMed ID: 15070697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.